Cargando…
Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System
PURPOSE: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this study was to evaluate outcomes in patients with m...
Autores principales: | Nguyen, Eric K., Lalani, Aly Khan A., Ghosh, Sunita, Basappa, Naveen S., Kapoor, Anil, Hansen, Aaron R., Kollmannsberger, Christian, Heng, Daniel, Wood, Lori A., Castonguay, Vincent, Soulières, Denis, Winquist, Eric, Canil, Christina, Graham, Jeffrey, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frédéric, Swaminath, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260099/ https://www.ncbi.nlm.nih.gov/pubmed/35814860 http://dx.doi.org/10.1016/j.adro.2022.100899 |
Ejemplares similares
-
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System
por: Cardenas, Luisa M., et al.
Publicado: (2023) -
Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma
por: Parmar, Ambica, et al.
Publicado: (2022) -
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review
por: Lalani, Aly-Khan A., et al.
Publicado: (2022) -
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey
por: Al-Ezzi, Esmail M., et al.
Publicado: (2023) -
Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report
por: Bondy, Suraya, et al.
Publicado: (2020)